Analyst Reco. OmniAb, Inc.

Equities

OABI

US68218J1034

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
4.54 ^USD	+1.34%		-2.16%	-26.42%

Mar. 25	OmniAb Insider Bought Shares Worth $1,167,750, According to a Recent SEC Filing	MT
Mar. 21	Sector Update: Health Care Stocks Gain Pre-Bell Thursday	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OmniAb Insider Bought Shares Worth $1,167,750, According to a Recent SEC Filing	Mar. 25	MT
RBC Initiates OmniAb at Outperform With $6 Price Target, Says Stock Gives Exposure to Growth Potential of Monoclonal Antibody Therapies	Nov. 29	MT
Benchmark Initiates OmniAb at Buy With $8 Price Target	23-04-21	MT
Craig-Hallum Initiates OmniAb at Buy Rating With $10 Price Target	23-04-13	MT
Cowen Initiates OmniAb at Outperform With $10 Price Target	23-02-22	MT
HC Wainwright Starts OmniAb at Buy With $11 Price Target	23-02-13	MT
Truist Starts OmniAb at Buy With $10 Price Target	22-12-20	MT
Credit Suisse Initiates OmniAb at Outperform Rating With $13 Price Target	22-12-16	MT
SVB Securities Starts OmniAb at Outperform With $6 Price Target	22-11-29	MT
Stifel Starts OmniAb at Buy With $12 Price Target	22-11-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer